Country experiences on the path to exclusive use of validated automated blood pressure measuring devices within the HEARTS in the Americas Initiative.
Cintia LombardiDean S PiconeJames E SharmanNorman R C CampbellRafael FariasStephanie GuerreAnselm GittensMelanie PaccotNilda VillacresYamile ValdesPedro OrdunezPublished in: Journal of human hypertension (2022)
The aim of the HEARTS in the Americas initiative is to promote the adoption of global best practices in the prevention and control of cardiovascular diseases, and improve the control of hypertension. HEARTS is being implemented in 21 countries and a diverse set of actions and measures are in progress to improve exclusive access in primary health care facilities to automated blood pressure measuring devices that have been validated for accuracy. The purpose of this manuscript is to illustrate these efforts, mainly in the regulatory and public procurement arena, and to present information on common challenges and solutions identified. Examples from six countries confirm the need for not only a robust regulatory framework to increase availability of validated automated blood pressure measuring devices but also a comprehensive strategic approach that involves relevant stakeholders, includes a multi-pronged approach and is associated with a national program to prevent and control non communicable diseases.
Keyphrases
- blood pressure
- quality improvement
- hypertensive patients
- machine learning
- deep learning
- high throughput
- heart rate
- healthcare
- cardiovascular disease
- transcription factor
- mental health
- blood glucose
- skeletal muscle
- type diabetes
- electronic health record
- health information
- metabolic syndrome
- insulin resistance
- cardiovascular events
- adverse drug